Pulse Biosciences, Inc. (PLSE)
USD 17.83
(-7.33%)
USD 17.83
(-7.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 700 Thousand | 1.41 Million | - | - | - |
| Cost of Revenue | 1.2 Million | 11.94 Million | 1.96 Million | 665 Thousand | 666 Thousand | 665 Thousand |
| Gross Profit | -1.2 Million | -11.24 Million | -550 Thousand | -665 Thousand | -666 Thousand | -665 Thousand |
| Operating Expenses | 43.57 Million | 46.81 Million | 62.46 Million | 49.96 Million | 47.95 Million | 37.96 Million |
| Selling, General and Administrative Expenses | 15.77 Million | 25.97 Million | 33.82 Million | 22.85 Million | 22.32 Million | 20.04 Million |
| Research and Development Expenses | 27.79 Million | 20.83 Million | 28.64 Million | 26.44 Million | 24.96 Million | 17.25 Million |
| Other Expenses | - | - | - | 665 Thousand | 666 Thousand | -28 Thousand |
| Cost and Expenses | 43.57 Million | 58.75 Million | 64.43 Million | 49.96 Million | 47.95 Million | 37.96 Million |
| Operating Income | -43.57 Million | -58.05 Million | -63.01 Million | -49.96 Million | -47.95 Million | -37.96 Million |
| Interest Expense | 1.36 Million | 448 Thousand | 646 Thousand | - | - | - |
| Income Tax Expense | - | 448 Thousand | -500 Thousand | -114 Thousand | -983 Thousand | -28 Thousand |
| Earnings before Tax | -42.21 Million | -58.5 Million | -63.66 Million | -49.85 Million | -46.97 Million | -37.54 Million |
| Net Income | -42.21 Million | -58.95 Million | -63.16 Million | -49.73 Million | -45.98 Million | -37.54 Million |
| Earnings Per Share Basic | -0.88 | -1.74 | -2.26 | -2.14 | -2.22 | -2.20 |
| Earnings Per Share Diluted | -0.88 | -1.74 | -2.26 | -2.14 | -2.22 | -2.20 |
| Weighted Average Shares Outstanding | 48.03 Million | 33.93 Million | 27.96 Million | 23.24 Million | 20.74 Million | 17.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.03 Million | 33.93 Million | 27.96 Million | 23.24 Million | 20.74 Million | 17.07 Million |
| Gross Margin | - | -16.06 | -0.39 | - | - | - |
| EBIT Margin | - | -82.94 | -44.44 | - | - | - |
| Profit Margin | - | -84.22 | -44.54 | - | - | - |
| EBITDA | -42.36 Million | -56.7 Million | -61.86 Million | -48.87 Million | -46.79 Million | -36.65 Million |
| Earnings Before Tax Margin | - | -82.94 | -44.44 | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 1.74 Million | - |
| Cost of Revenue | 267 Thousand | 266 Thousand | 299 Thousand | 1.2 Million | 304 Thousand | 266 Thousand |
| Gross Profit | -267 Thousand | -266 Thousand | -299 Thousand | -1.2 Million | 1.43 Million | -266 Thousand |
| Operating Expenses | 13.65 Million | 11.46 Million | 10.31 Million | 42.36 Million | 12.22 Million | 11.25 Million |
| Selling, General and Administrative Expenses | 5.95 Million | 4.23 Million | 3.57 Million | - | 4.43 Million | 3.78 Million |
| Research and Development Expenses | 7.7 Million | 7.23 Million | 6.74 Million | - | 7.79 Million | 7.47 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 13.65 Million | 11.72 Million | 10.61 Million | 43.57 Million | 12.53 Million | 11.25 Million |
| Operating Income | -13.65 Million | -11.72 Million | -10.61 Million | -43.57 Million | -12.53 Million | -11.25 Million |
| Interest Expense | - | - | 478 Thousand | 1.36 Million | 617 Thousand | 686 Thousand |
| Income Tax Expense | -267 Thousand | - | 255.72 Thousand | - | 123 Thousand | -299 Thousand |
| Earnings before Tax | -12.68 Million | -11.38 Million | -10.13 Million | -42.21 Million | -11.93 Million | -10.56 Million |
| Net Income | -12.68 Million | -11.38 Million | -10.13 Million | -42.21 Million | -11.93 Million | -10.56 Million |
| Earnings Per Share Basic | -0.21 | -0.20 | -0.18 | - | -0.22 | -0.19 |
| Earnings Per Share Diluted | -0.21 | -0.20 | -0.18 | - | -0.22 | -0.19 |
| Weighted Average Shares Outstanding | 61.06 Million | 57.18 Million | 55.17 Million | 48.03 Million | 55.05 Million | 54.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.06 Million | 57.18 Million | 55.17 Million | 48.03 Million | 55.05 Million | 54.92 Million |
| Gross Margin | - | - | - | - | 0.83 | - |
| EBIT Margin | - | - | - | - | -7.03 | - |
| Profit Margin | - | - | - | - | -6.86 | - |
| EBITDA | -13.65 Million | -11.46 Million | -10.31 Million | - | -12.22 Million | -11.25 Million |
| Earnings Before Tax Margin | - | - | - | - | -7.20 | - |
NIABY
AGXKF
MSLVF
CBRGU
600563
APRAF